EGFR tyrosine kinase inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EGFR tyrosine kinase inhibitor (unspecified), covering 2019-01-30 to 2025-02-19. Get the full timeline:
Most recent: Clinical Trial Update: Primary Tumor Resection With EGFR TKI for Stage IV NSCLC [Phase 2]